For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the development of personalized medicine approaches; however, given that they target human mutations and therefore human genetic sequences, scientists rely on the availability of humanized animal models. Here, we outline the usefulness, caveats and potential of such models, using the example of the hDMDdel52/ model, a humanized model recently generated for Duchenne muscular dystrophy (DMD).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906630 | PMC |
http://dx.doi.org/10.1242/dmm.041673 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!